CPAP Therapy Termination Rates by OSA Phenotype: A French Nationwide Database Analysis
The nationwide claims data lake for sleep apnoea (ALASKA)—real-life data for understanding and increasing obstructive sleep apnea (OSA) quality of care study—investigated long-term continuous positive airway pressure (CPAP) termination rates, focusing on the contribution of comorbidities. The French...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/5/936 |
id |
doaj-3cb40ebeb00f4eab81a67fab28127320 |
---|---|
record_format |
Article |
spelling |
doaj-3cb40ebeb00f4eab81a67fab281273202021-03-02T00:00:22ZengMDPI AGJournal of Clinical Medicine2077-03832021-03-011093693610.3390/jcm10050936CPAP Therapy Termination Rates by OSA Phenotype: A French Nationwide Database AnalysisJean-Louis Pépin0Sébastien Bailly1Pierre Rinder2Dan Adler3Daniel Szeftel4Atul Malhotra5Peter A. Cistulli6Adam Benjafield7Florent Lavergne8Anne Josseran9Renaud Tamisier10Pierre Hornus11on behalf of the medXcloud GroupHP2 Laboratory, University Grenoble Alpes, Inserm, CHU Grenoble Alpes, 38043 Grenoble, FranceHP2 Laboratory, University Grenoble Alpes, Inserm, CHU Grenoble Alpes, 38043 Grenoble, FranceSEMEIA, 75010 Paris, FranceFaculty of Medicine, University of Geneva, 1205 Geneva, SwitzerlandSEMEIA, 75010 Paris, FrancePulmonary, Critical Care and Sleep Medicine, University of California, San Diego, CA 92037, USACharles Perkins Centre, Faculty of Medicine and Health, University Sydney, Sydney, NSW 2006, AustraliaResMed Science Center, Sydney, NSW 2153, AustraliaResMed Science Center, 69791 Saint Priest, FranceResMed Science Center, 69791 Saint Priest, FranceHP2 Laboratory, University Grenoble Alpes, Inserm, CHU Grenoble Alpes, 38043 Grenoble, FranceSEMEIA, 75010 Paris, FranceThe nationwide claims data lake for sleep apnoea (ALASKA)—real-life data for understanding and increasing obstructive sleep apnea (OSA) quality of care study—investigated long-term continuous positive airway pressure (CPAP) termination rates, focusing on the contribution of comorbidities. The French national health insurance reimbursement system data for new CPAP users aged ≥18 years were analyzed. Innovative algorithms were used to determine the presence of specific comorbidities (hypertension, diabetes and chronic obstructive pulmonary disease (COPD)). Therapy termination was defined as cessation of CPAP reimbursements. A total of 480,000 patients were included (mean age 59.3 ± 13.6 years, 65.4% male). An amount of 50.7, 24.4 and 4.3% of patients, respectively, had hypertension, diabetes and COPD. Overall CPAP termination rates after 1, 2 and 3 years were 23.1, 37.1 and 47.7%, respectively. On multivariable analysis, age categories, female sex (1.09 (1.08–1.10) and COPD (1.12 (1.10–1.13)) and diabetes (1.18 (1.16–1.19)) were significantly associated with higher CPAP termination risk; patients with hypertension were more likely to continue using CPAP (hazard ratio 0.96 (95% confidence interval 0.95–0.97)). Therapy termination rates were highest in younger or older patients with ≥1 comorbidity. Comorbidities have an important influence on long-term CPAP continuation in patients with OSA.https://www.mdpi.com/2077-0383/10/5/936obstructive sleep apneacontinuous positive airway pressurecomorbiditiesadherencetreatment |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jean-Louis Pépin Sébastien Bailly Pierre Rinder Dan Adler Daniel Szeftel Atul Malhotra Peter A. Cistulli Adam Benjafield Florent Lavergne Anne Josseran Renaud Tamisier Pierre Hornus on behalf of the medXcloud Group |
spellingShingle |
Jean-Louis Pépin Sébastien Bailly Pierre Rinder Dan Adler Daniel Szeftel Atul Malhotra Peter A. Cistulli Adam Benjafield Florent Lavergne Anne Josseran Renaud Tamisier Pierre Hornus on behalf of the medXcloud Group CPAP Therapy Termination Rates by OSA Phenotype: A French Nationwide Database Analysis Journal of Clinical Medicine obstructive sleep apnea continuous positive airway pressure comorbidities adherence treatment |
author_facet |
Jean-Louis Pépin Sébastien Bailly Pierre Rinder Dan Adler Daniel Szeftel Atul Malhotra Peter A. Cistulli Adam Benjafield Florent Lavergne Anne Josseran Renaud Tamisier Pierre Hornus on behalf of the medXcloud Group |
author_sort |
Jean-Louis Pépin |
title |
CPAP Therapy Termination Rates by OSA Phenotype: A French Nationwide Database Analysis |
title_short |
CPAP Therapy Termination Rates by OSA Phenotype: A French Nationwide Database Analysis |
title_full |
CPAP Therapy Termination Rates by OSA Phenotype: A French Nationwide Database Analysis |
title_fullStr |
CPAP Therapy Termination Rates by OSA Phenotype: A French Nationwide Database Analysis |
title_full_unstemmed |
CPAP Therapy Termination Rates by OSA Phenotype: A French Nationwide Database Analysis |
title_sort |
cpap therapy termination rates by osa phenotype: a french nationwide database analysis |
publisher |
MDPI AG |
series |
Journal of Clinical Medicine |
issn |
2077-0383 |
publishDate |
2021-03-01 |
description |
The nationwide claims data lake for sleep apnoea (ALASKA)—real-life data for understanding and increasing obstructive sleep apnea (OSA) quality of care study—investigated long-term continuous positive airway pressure (CPAP) termination rates, focusing on the contribution of comorbidities. The French national health insurance reimbursement system data for new CPAP users aged ≥18 years were analyzed. Innovative algorithms were used to determine the presence of specific comorbidities (hypertension, diabetes and chronic obstructive pulmonary disease (COPD)). Therapy termination was defined as cessation of CPAP reimbursements. A total of 480,000 patients were included (mean age 59.3 ± 13.6 years, 65.4% male). An amount of 50.7, 24.4 and 4.3% of patients, respectively, had hypertension, diabetes and COPD. Overall CPAP termination rates after 1, 2 and 3 years were 23.1, 37.1 and 47.7%, respectively. On multivariable analysis, age categories, female sex (1.09 (1.08–1.10) and COPD (1.12 (1.10–1.13)) and diabetes (1.18 (1.16–1.19)) were significantly associated with higher CPAP termination risk; patients with hypertension were more likely to continue using CPAP (hazard ratio 0.96 (95% confidence interval 0.95–0.97)). Therapy termination rates were highest in younger or older patients with ≥1 comorbidity. Comorbidities have an important influence on long-term CPAP continuation in patients with OSA. |
topic |
obstructive sleep apnea continuous positive airway pressure comorbidities adherence treatment |
url |
https://www.mdpi.com/2077-0383/10/5/936 |
work_keys_str_mv |
AT jeanlouispepin cpaptherapyterminationratesbyosaphenotypeafrenchnationwidedatabaseanalysis AT sebastienbailly cpaptherapyterminationratesbyosaphenotypeafrenchnationwidedatabaseanalysis AT pierrerinder cpaptherapyterminationratesbyosaphenotypeafrenchnationwidedatabaseanalysis AT danadler cpaptherapyterminationratesbyosaphenotypeafrenchnationwidedatabaseanalysis AT danielszeftel cpaptherapyterminationratesbyosaphenotypeafrenchnationwidedatabaseanalysis AT atulmalhotra cpaptherapyterminationratesbyosaphenotypeafrenchnationwidedatabaseanalysis AT peteracistulli cpaptherapyterminationratesbyosaphenotypeafrenchnationwidedatabaseanalysis AT adambenjafield cpaptherapyterminationratesbyosaphenotypeafrenchnationwidedatabaseanalysis AT florentlavergne cpaptherapyterminationratesbyosaphenotypeafrenchnationwidedatabaseanalysis AT annejosseran cpaptherapyterminationratesbyosaphenotypeafrenchnationwidedatabaseanalysis AT renaudtamisier cpaptherapyterminationratesbyosaphenotypeafrenchnationwidedatabaseanalysis AT pierrehornus cpaptherapyterminationratesbyosaphenotypeafrenchnationwidedatabaseanalysis AT onbehalfofthemedxcloudgroup cpaptherapyterminationratesbyosaphenotypeafrenchnationwidedatabaseanalysis |
_version_ |
1724245656981209088 |